MissionIR Articles
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Closes on $6.5M Registered Direct Offering
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has closed on its registered direct offering. The offering, which was priced in accordance with NASDAQ guidelines, iincluded the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) and warrants…
-
MissionIRNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Serving Residential, Commercial Markets Amid Anticipated Growth in Demand for Solar Systems
Turbo Energy (NASDAQ: TURB), a photovoltaic energy company based in Spain, anticipates increased demand for residential solar energy systems from homeowners in the EU and throughout the world. “The company’s flagship product – SunBox – is an all-in-one residential solar energy solution that leverages AI to manage consumption, reduce expenses and protect consumers from price…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Increased Interest for Microgrid and Clean Energy Solutions
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is positioned as as demand for resilient, clean energy continues to trend in the United States. Amidst this backdrop, the company is seeing an increasing number of corporate clients partnering with its microgrid and clean energy strategies. “Correlate…
-
MissionIRNewsBreaks – Why Bravo Multinational Inc. (BRVO) Is ‘One to Watch’
Bravo (OTC: BRVO), a company focused on pioneering innovative solutions in the digital content landscape, is actively exploring opportunities in the entertainment, hospitality and technology sectors. “In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, marking a pivotal step in establishing its flagship offering, aptly named TVee NOW(TM). The acquired assets…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO to Present at the Upcoming 14th Annual LD Micro Invitational
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that it will be participating at the 14th Annual LD Micro Invitational at the Sofitel New York on Apr. 8-9, 2024. Lexaria CEO Chris Bunka will be presenting at the event, with his presentation scheduled to begin at 10:30 a.m. ET…
-
MissionIRNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR), CEO Recognized at FiNext Conference with Excellence in Finance Awards
FingerMotion (NASDAQ: FNGR), a mobile services and data company, and CEO Martin J. Shen, received recognition at the recent FiNext Conference. At the conference, which was held in Dubai on Feb. 28–29, 2024, FingerMotion and Shen both received awards. Shen was awarded the Excellence in Finance — Leaders Award, and the company was awarded the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has been granted an additional 180 days to comply with NASDAQ’s minimum bid price requirement for the continued listing on the NASDAQ Capital Market. InMed received a letter from the exchange notifying it of the extended…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continuing to Redefine Logistics Landscape with Innovative Solutions
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has been Riisa’s trusted logistics supplier for over two years, facilitating cross-border exportations and enabling Riisa to move its products with ease and efficiency.…
-
MissionIRNewsBreaks – Why Zoned Properties Inc. (ZDPY) Is ‘One to Watch’
Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focused on acquiring value-add real estate within the U.S. regulated cannabis industry. “The company aspires to innovate, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers. The company is redefining the approach to commercial real estate…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients
PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”), is focusing its lead program on autism spectrum disorder (“ASD”), for which there is no approved pharmacologic treatment targeting cause and symptoms. “The current ASD treatments only address the symptoms of the condition but do not target the pathophysiology…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares…
-
MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Expanding Operations Within Agricultural Sectors
SenesTech (NASDAQ: SNES), a rodent pest control enterprise, has begun to establish a global reach for its innovative Birth Control for Rats(TM) products. “The company is expanding its operations within agricultural sectors where rodent predation may otherwise have costly effects on food markets. On Jan. 29, SenesTech announced the signing of a distribution agreement with…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering
Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares…
-
MissionIRNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast
Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial EVP Rich McCormick, the podcast is available for on-demand listening on First in Human by…
-
MissionIRNewsBreaks – Turbo Energy S.A. (NASDAQ: TURB) Providing ‘Best on the Market’ AI-Driven System
Turbo Energy (NASDAQ: TURB) is a designer, developer and manufacturer of photovoltaic energy generation, management and storage equipment. The company is seeking to harness artificial intelligence (“AI”) in the manufacture and development of its residential solutions, which allow households to capture and store solar energy. “The company’s ‘Sunbox Home’ system encompasses an all-in-one AI-powered energy…
-
MissionIRNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Is Expanding Global Reach with Innovative Products
SenesTech (NASDAQ: SNES) is dramatically improving pest management technicians’ toolboxes with its patent-pending Evolve(R) soft bait birth control product for rodents, which joins the liquid ContraPest(TM) product in providing non-lethal solutions to reducing rodent populations. “The patent-pending Evolve(TM) soft bait has a sausage-like appearance and poses little or no risk to human health or the…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI), Carbonsight Create Powerful Synergy, Empower Navigation to Low-Carbon Future
Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, recently announced a strategic partnership with Carbonsight (by Autocase). “This move brings together Carbonsight’s cutting-edge decarbonization planning software and Correlate’s expertise in developing and financing renewable and clean energy projects, together helping businesses transition to a low-carbon future……
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Announces Further Amendments to Iska Iska Payment Schedule
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, has amended the payment schedule for its Iska Iska silver-tin polymetallic project. The amendment was made by mutual agreement with Empresa Minera Villegas S.R.L., title holder of the project, which is located in the Potosi Department in southern Bolivia. This…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Closes $7.4M Registered Direct as Company Targets Cash Flow Positive in Q1 2026
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q3 Results and Advances Lead Candidate TPI 287 Toward Phase 2 GBM Study
- MissionIRNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Secures First Missouri Contract as PureSecurity Platform Displaces Incumbent Provider
- Safe & Green Holdings Corp. (NASDAQ: SGBX) Sets December 29 Annual Meeting as It Advances Energy Strategy and Finalizes Olenox–Safe & Green Merger
- MissionIRNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Highlights Operational Progress Following $20 Million in Strategic Investments